September 12, 2012
GREENWICH, CT and ANN ARBOR, MI – September 12, 2012 – Great Point Partners I portfolio company, Biotronic NeuroNetwork (“Biotronic”), today announced the appointment of Dane A. Miller, Ph.D., former CEO and Founder of Biomet Inc., to its Board of Directors. Dr. Miller served as President and CEO of Biomet since its inception in 1978 until retiring in March of 2006. With Dr. Miller at the helm, Biomet grew from $17,000 in sales its first year into one of the leading musculoskeletal companies in the world – with annual sales exceeding $2.7 billion and grew from eight employees to more than 10,000 globally. Dr. Miller continues to serve on Biomet’s Board of Directors.
Greg W. Sasso, CEO of Biotronic, expressed excitement at Dr. Miller’s appointment, “As we expand our industry leading services across the nation, we wanted to add an admired executive and visionary person with unparalleled industry expertise to the board. We are honored to have Dr. Miller join our Board of Directors.”
Dr. Miller added, “Biotronic is committed to providing the highest quality intra-operative neuromonitoring services and delivering real value to their customers and their patients. I am excited to become a Board member of Biotronic.”
Adam B. Dolder, Managing Director of Great Point Partners and Chairman of Biotronic, said, “We are thrilled to have Dr. Miller join the board of Biotronic. Dr. Miller is a luminary in the industry and has an unparalleled track record of success in building, and helping build, great companies. His experiences will serve the Company exceptionally well.”
Founded in 1978, Biotronic NeuroNetwork is headquartered in Ann Arbor, Michigan and currently employs over 225 administrative, support and clinical staff, including over 160 technicians throughout the country. Biotronic is the largest independent provider of intraoperative neurophysiological monitoring in the world, serving over 450 hospitals and 1,200 surgeons annually. www.biotronic.com.
About Great Point Partners
GPP, based in Greenwich, CT, is a leading health care investment firm with approximately $500 million of equity capital under management. The firm manages capital in public and private equity funds. Great Point Partners has provided growth equity, growth recapitalization, and management buyout financing to more than 100 health care companies. Both the private and public funds invest across all sectors of the health care industry including behavioral health, biologics manufacturing, biotechnology and life sciences, health care services, hospital outsourcing, information technology, medical devices, specialty pharmaceuticals, and workers compensation. The firm pursues a proactive and proprietary approach to sourcing investments. Reach Great Point at 203.971.3300. www.gppfunds.com
This document is intended solely to provide information regarding Great Point Partners’ potential financing capabilities for prospective portfolio companies.